Kintu K, Malaba T, Nakibuka J, et al. RCT of Dolutegravir vs Efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2. CROI 2019, abstract 40-LB.
Behandeling van HCV met direct werkende antivirale middelen kan HBV reactiveren
jan 2018 | Hepatitis